Shoulder Innovations, Inc. (SI) PE Ratio: N/A
The P/E ratio for Shoulder Innovations, Inc. (SI) is N/A as of Sunday, June 21, 2026.
SI PE Ratio Metrics
PE RATIO
N/A
SI Competitors' PE Ratio
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $384.69M | N/A | N/A | N/A | N/A |
| 23andMe Holding Co. (ME)vs › | $15.31M | N/A | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.07B | N/A | 23.81 | 50.79 | 57.43 |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 18.03 | 48.69 | 544.39 | 544.39 |
| Oscar Health, Inc. (OSCR)vs › | $7.36B | N/A | 60.92 | 60.92 | 60.92 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.64B | 46.53 | 24.59 | 24.59 | 12.65 |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.91B | N/A | 61.96 | 88.48 | 88.48 |
| Tempus AI, Inc. (TEM)vs › | $8.87B | N/A | N/A | N/A | N/A |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.91B | N/A | 225.66 | 91.39 | 72.20 |
| Baxter International Inc. (BAX)vs › | $10.27B | N/A | 44.53 | 34.41 | 37.43 |
P/E Comparison
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E Calculation
View All Analyst EstimatesForward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$18.55
Forward EPS (Est.)
$-1.70
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
Shoulder Innovations, Inc. PE Ratio Formula & Definition
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
About Shoulder Innovations, Inc.
Shoulder Innovations, Inc. is a medical technology firm that engineers and produces sophisticated devices. The company is particularly recognized for designing an innovative shoulder replacement system. Co-founded in 2009 by Stephen B. Gunther and Michael DeVries, its main corporate office is situated in Grand Rapids, Michigan.
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Alan J. Lane